We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Receptor Blueprint Helps Design Osteoporosis Drugs

News   Nov 20, 2018 | Original story from University of Zurich

 
Receptor Blueprint Helps Design Osteoporosis Drugs

The receptor is the key regulatory switch controlling calcium release from bones, and thus a prime target for developing new drugs for the treatment of osteoporosis. The receptor consists of an extracellular part (purple) and a part that resides in the membrane (green). Parathyroid hormone (orange) activates the receptor. Credit: University of Zurich

 
 
Advertisement
 

RELATED ARTICLES

Team Uncovers New Mechanism of Action Against SARS-CoV-2 by Remdesivir

News

Researchers have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2, according to findings published in the Journal of Biological Chemistry.

READ MORE

Researchers Develop New Method To Print Tiny, Functional Organs

News

Researchers at EPFL have developed an approach to print tiny tissues that look and function almost like their full-sized counterpart. Measuring just a few centimeters across, the mini-tissues could allow scientists to study biological processes—and even test new treatment approaches—in ways that were previously not possible.

READ MORE

Patients Taking Certain HIV Drugs Had a 33% Lower Risk of Developing Diabetes

News

A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent Type 2 diabetes, according to a newly published study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE